BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 4451721)

  • 1. [Effect of the rhythm of cyclophosphamide administration on its antitumor action and on the immune response of mice with methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM; Botsmanov KV
    Biull Eksp Biol Med; 1974 Jul; 78(7):87-90. PubMed ID: 4451721
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of different doses of cyclophosphamide on the immune response of mice with a methylcholanthrene-induced sarcoma].
    Gordienko SP; Bergol'ts VM
    Vopr Onkol; 1973; 19(11):54-60. PubMed ID: 4785975
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the rhythm of cyclophosphamide administration on its antitumor action and the immune response of mice with methylcholanthrene sarcoma.
    Gordineko SP; Bergol'ts VM; Botsmanov KV
    Bull Exp Biol Med; 1975 Jan; 77(7):803-5. PubMed ID: 1115864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.
    Livingston PO; DeLeo AB; Jones M; Oettgen HF
    J Immunol; 1983 Nov; 131(5):2601-5. PubMed ID: 6631013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of the cyclophosphane administration regimen for its immunomodulating and antitumor effect in experimental chemotherapy].
    Kovbasiuk SA
    Vopr Onkol; 1985; 31(7):91-7. PubMed ID: 4024566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of some cell surface modifications on the cytotoxic effect of immune lymphocytes in vitro].
    Brondz BD; Shamborant OG
    Tsitologiia; 1972 Feb; 14(2):189-96. PubMed ID: 5062397
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antitumor activity of the serum and lymphocytes of C57BL mice in chemical carcinogenesis].
    Umanskiĭ IuA; Kushko LIa; Semenova-Kobzar' RA
    Vopr Onkol; 1980; 26(2):42-6. PubMed ID: 7361493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy.
    Focan C; Barbason H; Betz EH
    Biomedicine; 1975 Jun; 23(6):230-5. PubMed ID: 1240011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated cytotoxicity of adherent and non-adherent mouse lymph node cells sensitized in vitro against tumour-associated antigens of syngenetic methylcholanthrene-induced sarcomas.
    Indrová M; Bubeník J
    Folia Biol (Praha); 1979; 25(2):137-41. PubMed ID: 456694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tumor size on concomitant tumor immunity.
    Deckers PJ; Davis RC; Parker GA; Mannick JA
    Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
    Kitano M; Okada Y; Nagaishi C
    Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of T and B-lymphocytes in macrophage migration inhibition in mice with methylcholanthrene-induced sarcoma].
    Galussio JC; Fridman JL; Tessler J
    Medicina (B Aires); 1977; 37(3):264-70. PubMed ID: 302386
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
    Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
    Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro studies of the influence of the immune status of C3Hf-Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma.
    Jurin M; Suit HD
    Cancer Res; 1972 Oct; 32(10):2201-11. PubMed ID: 5080765
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of immunocompetence assays for defining immunosuppression.
    Dean JH; Padarathsingh ML; Jerrells TR
    Ann N Y Acad Sci; 1979 May; 320():579-90. PubMed ID: 110201
    [No Abstract]   [Full Text] [Related]  

  • 19. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

  • 20. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.